Analysis of Immune Status Following Hypofractionated vs. Conventionally Fractionated Radiation Therapy
S
Susannah Ellsworth, MD
Primary Investigator
Overview
The purpose of this study is to collect blood samples from patients with cancer before and after radiation therapy in order to examine immune response to radiation therapy.
Description
The purpose of this study is to collect blood samples from patients with cancer before and after radiation therapy in order to examine immune response to radiation therapy.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
cancer
-
Age: - 100 Years
-
Gender: All
Inclusion Criteria
In order to be eligible to take part in this trial, patients must have:
- Histologically confirmed solid malignancy (carcinoma/sarcoma/melanoma)
- Life expectancy ≥ 3 months
Updated on
15 Apr 2024.
Study ID: 1611048419 (IUSCC-0582)
